Risankizumab

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate ResponseNCT06641089MoonLake Immunotherapeutics AGPhase 3Active not recruiting2027-01-04Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.